Partnerships

Teaming up to change the face of cancer care and push better health to new heights.

Cancer Care Partnerships and Collaborations

Partnering with leading organizations to deliver the next generation of cancer care, bringing access, speed, and oncologist-led clinical expertise to every stage of the journey, from identifying risk and detecting cancer earlier to guiding treatment and supporting survivorship.

Color Health and Google Cloud are partnering to expand access to breast cancer screening, augmenting clinical care with AI.

Color Health and Google Cloud are partnering to expand access to breast cancer screening, augmenting clinical care with AI.

The social impact effort expedites access to essential healthcare services through AI, while decreasing physician burden. With a generative AI agent called Color Assistant, the companies are pairing Color’s oncologist-led Virtual Cancer Clinic with AI built by Google Cloud to quickly determine eligibility for mammograms, schedule breast cancer screenings, and coordinate follow up.

Color and the American Cancer Society (ACS) are partnering to boost cancer screening rates through employers and unions.

Color and the American Cancer Society (ACS) are partnering to boost cancer screening rates through employers and unions.

By combining ACS’s trusted guidelines and patient resources with Color’s Virtual Cancer Clinic, we make it easier for people to get the care they need—across every stage of the journey. Together, we’re helping organizations deliver evidence-based Cancer Care that’s more proactive, more personal, and easier to access.

Color Health and Carrum Health are partnering to connect proactive clinical care with Centers of Excellence for cancer treatment.

Color Health and Carrum Health are partnering to connect proactive clinical care with Centers of Excellence for cancer treatment.

The collaboration unites Color’s oncologist-led Virtual Cancer Clinic with Carrum’s bundled Centers of Excellence network. Together, the companies help employers deliver faster, clinically guided care from prevention through treatment and survivorship, reducing fragmentation, speeding access to care, and lowering costs through a single model that improves outcomes and simplifies the cancer benefit experience.

MSK Direct offers expert Cancer Care from Memorial Sloan Kettering—but access can still be a barrier. Color and MSK teamed up to change that.

MSK Direct offers expert Cancer Care from Memorial Sloan Kettering—but access can still be a barrier. Color and MSK teamed up to change that.

Our collaboration brings MSK’s world-class care together with Color’s nationwide Virtual Cancer Clinic, making it possible for employees everywhere to get timely diagnosis, treatment, and support—no matter where they live.

Color and Collective Health are partnering to shift cancer care from reactive to proactive.

Color and Collective Health are partnering to shift cancer care from reactive to proactive.

Members access Color’s Virtual Cancer Clinic directly through the My Collective™ portal, with integrations that enable seamless care, eligibility tracking, and outcomes reporting. The result: faster diagnosis, fewer ER visits, and better support—powered by data and driven by compassion.

Built with OpenAI’s LLM model and tested with UCSF, Color’s AI-powered Cancer Copilot helps clinicians deliver guideline-based Cancer Care in minutes.

Built with OpenAI’s LLM model and tested with UCSF, Color’s AI-powered Cancer Copilot helps clinicians deliver guideline-based Cancer Care in minutes.

It achieved over 95% concordance on real-world patient cases and includes transparent logic for clinical oversight. By combining speed with expert guidance, the Copilot brings high-quality Cancer Care to more settings—from leading centers to local clinics.

Scientific Partnerships and Collaborations

Collaborating with top institutions and research partners to advance cancer science through data, clinical insight, and innovation that improves cancer care for every person, at every stage.

Color is a lead partner in All of Us, a national initiative to return health-related genetic information to over one million people.

Color is a lead partner in All of Us, a national initiative to return health-related genetic information to over one million people.

We’re one of three Clinical Validation Laboratories and the sole provider of genetic counseling—helping deliver meaningful insights to a more diverse population.

Color is the exclusive genomic testing partner for the WISDOM trial—a 100,000-person study comparing annual mammograms to personalized, risk-based screening.

Color is the exclusive genomic testing partner for the WISDOM trial—a 100,000-person study comparing annual mammograms to personalized, risk-based screening.

In partnership with the University of California system and Sanford Health, we’re expanding access to smarter breast cancer prevention strategies.

Color provides clinical genetic testing for PROMISE, a national prostate cancer registry exploring the role of inherited mutations in outcomes and treatment.

Color provides clinical genetic testing for PROMISE, a national prostate cancer registry exploring the role of inherited mutations in outcomes and treatment.

Led by Johns Hopkins and Fred Hutch, this study is shaping new standards in prostate Cancer Care.

Through the GENTleMEN study, Color is working with Fred Hutch and the University of Washington to expand access to genetic testing and counseling for men with advanced prostate cancer.

Through the GENTleMEN study, Color is working with Fred Hutch and the University of Washington to expand access to genetic testing and counseling for men with advanced prostate cancer.

Together, we’re removing cost and location as barriers—helping more men get the insights they need to guide care.

In partnership with barbershops across Cleveland, Color and Case Western are helping more Black men access hereditary cancer testing and counseling.

In partnership with barbershops across Cleveland, Color and Case Western are helping more Black men access hereditary cancer testing and counseling.

The Cleveland African American Prostate Cancer Project (CAAPP) study brings care into trusted spaces—reducing racial gaps in cancer detection.

The Genetic Information and Family Testing (GIFT) study gives cancer patients a way to support their families through affordable genetic testing and personalized guidance.

The Genetic Information and Family Testing (GIFT) study gives cancer patients a way to support their families through affordable genetic testing and personalized guidance.

It’s helping researchers understand what drives participation in family-based cancer prevention.